AN AUSTRALIAN investigation
into the weight loss combination
therapy phentermine and
topiramate has demonstrated
efficacy but questionable
tolerability.
More than half of the 103 patients
dispensed the combination product
as a weight loss support therapy at
the Austin Health Weight Control
Clinic were unable to complete
the course because of adverse
events such as paraesthesia,
cognitive changes, dry mouth and
depression.
For those who were able to
tolerate the product, the results
were positive, with a mean weight
decrease of 6.7 kg.
In addition, the combination
was described by the authors as
efficacious for both maintenance of
weight loss and ongoing weight loss.
CLICK HERE to see the MJA paper.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Aug 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Aug 14
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.